L2.5 (Letrozole 2.5 mg)

Pill with imprint L2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Aurobindo Pharma Limited.

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L2.5

Letrozole

Imprint

L2.5

Strength

2.5 mg

Color

Yellow

Shape

Round

Availability

Prescription only

Drug Class

Aromatase inhibitors, Hormones/antineoplastics

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Aurobindo Pharma Limited

Manufacturer

Sun Pharmaceutical Industries Ltd.

National Drug Code (NDC)

59651-0180

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related Images for "L2.5"

Benadryl Allergy Ultratab

Clozaril

Lotrel

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer